DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT07360262

Completed

Gastric Emptying Recovery After GLP-1 RA Cessation

Time-dependent Recovery of Gastric Emptying After Cessation of Glucagon-like Peptide-1 Receptor Agonists: a Prospective Observational Gastric Ultrasound Study

Asset

GLP-1 / incretin class catch-all

Listed sites

2

Recruiting sites

—

Enrollment

186

actual

Study population

Perioperative / gastric aspiration risk

Key I/E criterion

—

Primary endpoint

•Ultrasound-estimated gastric volume (mL/kg)

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT07360262
Org study IDWonkwang UH 23

Timeline

Milestones

Study start2025-11-20actual
Primary completion2025-12-10actual
Study completion2026-01-12actual
Study first posted2026-01-22actual
Last update posted2026-01-23actual

Assets

Investigational agents

GLP-1 / incretin class catch-all

Study populations

Who this study enrolls

Perioperative / gastric aspiration risk

Eligibility

Who can enroll

Minimum age18 Years
SexAll
Healthy volunteersNot accepted
Sampling methodNon probability sample

Study population text

Adult patients receiving GLP-1 receptor agonists who were scheduled for elective surgery under general anesthesia at a tertiary academic hospital and underwent preoperative point-of-care gastric ultrasound immediately prior to induction of anesthesia.

Inclusion criteria

•Adults aged ≥18 years
•Receiving a glucagon-like peptide-1 receptor agonist (GLP-1 RA)
•Scheduled for elective surgery under general anesthesia
•Able to provide written informed consent

Exclusion criteria

•Prior gastric or esophageal surgery
•Known gastroparesis
•Severe gastroesophageal reflux disease
•Emergency surgery
•Pregnancy
•Inability to provide informed consent

Endpoints (3)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Other clinical outcomes

3 endpoints
Primary/protocol endpoint

Ultrasound-estimated gastric volume (mL/kg)

Time frame:Immediately preoperatively (just before induction of anesthesia)

descriptive

Secondary/protocol endpoint

Perlas grade of gastric content (0-2)

Time frame:Immediately preoperatively (just before induction of anesthesia)

categorical status, descriptive

Secondary/protocol endpoint

Antral cross-sectional area (CSA, cm²)

Time frame:Immediately preoperatively (just before induction of anesthesia)

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.